Analyzing 435,000 UK Biobank participants, a study published Aug. 31 in the journal Parkinson’s Disease found no significant link between coffee drinking and Parkinson’s risk across the population as a whole. After following adults for a median of 15.7 years, during which 3,319 participants developed Parkinson’s disease, researchers found that the association between coffee and disease risk changes depending on the specific CYP1A2 gene variation. This gene influences how the liver breaks down caffeine. The study followed adults who did not have Parkinson’s disease at the start of the investigation. Researchers grouped participants according to a common variation in the CYP1A2 gene associated with either faster or slower caffeine metabolism in the liver. Among fast caffeine metabolizers, drinking less than 5 cups per day associated with a 17% lower risk of Parkinson’s compared to drinking no coffee, with the apparent benefit being greatest at about 3 cups per day. In contrast, the results flipped for slow metabolizers who consumed 5 or more cups per day.

Metabolism Type Coffee Intake Parkinson’s Risk Change
Fast < 5 cups/day 17% lower risk
Slow 5+ cups/day 43% to 84% higher risk

One slower-metabolizing group saw a 43% higher Parkinson’s risk, while the group with the slowest metabolism faced an 84% higher risk. The lower-risk association among fast metabolizers was most apparent in women, while the higher risk among slow metabolizers appeared mainly in men, even though the researchers found the sex differences were not statistically significant.

Self-treatment and study limitations

A 2024 study found people use coffee to self-treat Parkinson’s symptoms but do not talk to their doctors about it. The observational study published in Parkinson’s Disease cannot prove coffee caused these risks because it relies on self-reported consumption from the start and analyzes caffeinated and decaffeinated coffee together. These findings explain why previous coffee and Parkinson’s studies produced different results, as individual responses to caffeine vary substantially. The research received support from the Shanghai Key Technology R&D Program, the National Natural Science Foundation of China, and the Key Laboratory of Exercise and Health Sciences at Shanghai University of Sport.

Spotted an error? Ask for a correction · Our editorial standards